HAE:TSX
MONTREAL, June 11 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX : HAE) released today the results of its second quarter ended April 30, and reports on its recently concluded strategic collaboration with Angiotech Pharmaceuticals, Inc.
Stategic Collaboration
As previously announced on June 3, 2009, Angiotech Pharmaceuticals, Inc.

HAE:TSX
- Loan of US$2.5 Million Expected to Close by June 1, 2009
MONTREAL, May 22 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company, announces that it and Angiotech Pharmaceuticals, Inc.

VANCOUVER, May 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its Quill(TM) SRS wound closure product line is now available for purchase online in the U.S. on its website at https://ecommerce.angiotech.com/Main/Home.aspx.